Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luyang Yu

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Circulation Research|August 17, 2023
Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary HypertensionXiaofei Zhou, Yuanqing Jiang, Yuewen Wang, et al.
Hypertension (Dallas, Tex. : 1979)|August 8, 2022
Tacrolimus Causes Hypertension by Increasing Vascular Contractility via RhoA (Ras Homolog Family Member A)/ROCK (Rho-Associated Protein Kinase) Pathway in MiceXiaohua Wang, Shan Jiang, Lingyan Fei, et al.
Nature Communications|November 14, 2022
Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylationChengyu Shi, Ying Wang, Minjie Wu, et al.
Nature Communications|December 10, 2024
Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylationChengyu Shi, Ying Wang, Minjie Wu, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Circulation Research|August 17, 2023
Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary HypertensionXiaofei Zhou, Yuanqing Jiang, Yuewen Wang, et al.
Hypertension (Dallas, Tex. : 1979)|August 8, 2022
Tacrolimus Causes Hypertension by Increasing Vascular Contractility via RhoA (Ras Homolog Family Member A)/ROCK (Rho-Associated Protein Kinase) Pathway in MiceXiaohua Wang, Shan Jiang, Lingyan Fei, et al.
Nature Communications|November 14, 2022
Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylationChengyu Shi, Ying Wang, Minjie Wu, et al.
Nature Communications|December 10, 2024
Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylationChengyu Shi, Ying Wang, Minjie Wu, et al.
Pageof 8